头颈癌：一种不断演变的治疗模式。
Head and neck cancer: an evolving treatment paradigm.
作者信息
Cognetti David M, Weber Randal S, Lai Stephen Y
机构信息
Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
出版信息
Cancer. 2008 Oct 1;113(7 Suppl):1911-32. doi: 10.1002/cncr.23654.
Abstract
Since the inception of this journal in 1948, the understanding of etiologic factors that contribute to and the treatment of head and neck cancer has evolved dramatically. Advances in surgery, radiation therapy, and chemotherapy have improved locoregional control, survival, and quality of life. The outcomes of these treatment modalities have shifted the focus of curative efforts from radical ablation to preservation and restoration of function. This evolution has been documented in the pages of Cancer for the past 6 decades. This review focuses on the evolution of treatment approaches for head and neck cancer and future directions while recognizing the historic contributions recorded within this journal.
摘要
自本期刊于1948年创刊以来，对头颈部癌症致病因素的认识以及治疗方法都发生了巨大的演变。手术、放射治疗和化学疗法的进展改善了局部区域控制、生存率和生活质量。这些治疗方式的成果已将治愈努力的重点从根治性切除转移至功能的保留和恢复。在过去60年里，《癌症》期刊的各期都记录了这一演变过程。本综述着重探讨头颈部癌症治疗方法的演变及未来方向，同时铭记本期刊所记载的历史性贡献。
相似文献
1
Head and neck cancer: an evolving treatment paradigm.
Cancer. 2008 Oct 1;113(7 Suppl):1911-32. doi: 10.1002/cncr.23654.
2
[Development of treatments for head and neck squamous cell carcinomas].
Gan To Kagaku Ryoho. 1999 Jun;26 Suppl 1:85-96.
3
Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):26-35. doi: 10.1001/archotol.129.1.26.
4
The role of neck dissection in squamous cell carcinoma of the head and neck.
Curr Treat Options Oncol. 2014 Dec;15(4):611-24. doi: 10.1007/s11864-014-0311-7.
5
Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
Curr Opin Oncol. 2010 May;22(3):206-11. doi: 10.1097/CCO.0b013e328338475c.
6
Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Oncology. 2008;75(3-4):186-91. doi: 10.1159/000163058. Epub 2008 Oct 8.
7
Head and neck squamous cancers.
Curr Probl Cancer. 1990 Jan-Feb;14(1):1-72.
8
The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.
Asia Pac J Clin Oncol. 2011 Sep;7(3):236-51. doi: 10.1111/j.1743-7563.2011.01420.x.
9
Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Radiat Oncol. 2018 Jul 3;13(1):123. doi: 10.1186/s13014-018-1067-1.
10
Supportive Care and Survivorship Strategies in Management of Squamous Cell Carcinoma of the Head and Neck.
Hematol Oncol Clin North Am. 2015 Dec;29(6):1159-68. doi: 10.1016/j.hoc.2015.07.010. Epub 2015 Sep 9.
引用本文的文献
1
Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer.
Cell Oncol (Dordr). 2025 May 20. doi: 10.1007/s13402-025-01061-w.
2
Targeting the Glucose-Insulin Link in Head and Neck Squamous Cell Carcinoma Induces Cytotoxic Oxidative Stress and Inhibits Cancer Growth.
Cancer Res Commun. 2025 Jun 1;5(6):921-938. doi: 10.1158/2767-9764.CRC-23-0506.
3
Challenges in chemotherapy for head and neck cancer: A review.
Bioinformation. 2025 Feb 28;21(2):121-126. doi: 10.6026/973206300210121. eCollection 2025.
4
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study.
EBioMedicine. 2025 Jan;111:105496. doi: 10.1016/j.ebiom.2024.105496. Epub 2024 Dec 12.
5
Artificial Intelligence in Head and Neck Cancer Diagnosis: A Comprehensive Review with Emphasis on Radiomics, Histopathological, and Molecular Applications.
Cancers (Basel). 2024 Oct 27;16(21):3623. doi: 10.3390/cancers16213623.
6
Evaluation of A. actinomycetemcomitans and P. gingivalis from the mouth of patients irradiated in the head and neck region: a cross-sectional study.
Support Care Cancer. 2024 Nov 4;32(11):770. doi: 10.1007/s00520-024-08970-w.
7
A Novel Split-Course High-Dose Palliative Radiotherapy Regimen for Locally Advanced Sinonasal Cancer: A Case Report.
Case Rep Oncol Med. 2024 Oct 3;2024:9340657. doi: 10.1155/2024/9340657. eCollection 2024.
8
Exploring transitions in care among patients with head and neck CANCER: a multimethod study.
BMC Cancer. 2024 Sep 5;24(1):1108. doi: 10.1186/s12885-024-12862-x.
9
Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders.
Oral Oncol. 2024 Nov;158:106986. doi: 10.1016/j.oraloncology.2024.106986. Epub 2024 Aug 12.
10
Impact of Preoperative Multidisciplinary Conference on Head and Neck Reconstruction Outcomes.
Laryngoscope. 2025 Jan;135(1):110-117. doi: 10.1002/lary.31665. Epub 2024 Jul 30.
本文引用的文献
1
Conservative surgery of cancer of the larynx.
Trans Am Acad Ophthalmol Otolaryngol. 1947 Jul-Aug;51:633-42.
2
Some epidemiological features of cancer.
Cancer. 1948 Sep;1(3):489-97. doi: 10.1002/1097-0142(194809)1:3<489::aid-cncr2820010317>3.0.co;2-6.
3
Minimally invasive video-assisted thyroidectomy: expanded indications and oncologic completeness.
Head Neck. 2008 Nov;30(11):1403-7. doi: 10.1002/hed.20883.
4
Endoscopic skull base surgery: principles of endonasal oncological surgery.
J Surg Oncol. 2008 Jun 15;97(8):658-64. doi: 10.1002/jso.21020.
5
Head and neck cancer: changing epidemiology, diagnosis, and treatment.
Mayo Clin Proc. 2008 Apr;83(4):489-501. doi: 10.4065/83.4.489.
6
"Not one single case of throat irritation": misuse of the image of the otolaryngologist in cigarette advertising.
Laryngoscope. 2008 Mar;118(3):415-27. doi: 10.1097/MLG.0b013e31815ad5c6.
7
Feasibility of flap reconstruction in conjunction with intraoperative radiation therapy for advanced and recurrent head and neck cancer.
Laryngoscope. 2008 Jan;118(1):69-74. doi: 10.1097/MLG.0b013e3181559ff7.
8
Expanding role of the medical oncologist in the management of head and neck cancer.
CA Cancer J Clin. 2008 Jan-Feb;58(1):32-53. doi: 10.3322/CA.2007.0004. Epub 2007 Dec 20.
9
Factors predictive of survival in advanced laryngeal cancer.
Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1270-6. doi: 10.1001/archotol.133.12.1270.
10
Sentinel lymph node biopsy in squamous cell carcinoma of the head and neck: where we stand now, and where we are going.
J Otolaryngol. 2007 Dec;36(6):344-9.
Zotero 插件